Medtronic’s Arsenal of Technology Driving Growth

Medtronic reported FY 3Q23 orthopedic sales of $807.3 million, +3.7% compared to the prior year.

The company is in the midst of a transformation designed to simplify its structure, devote more resources to high-growth opportunities and divest non-core assets to attain durable growth.

Like many of its peers, Medtronic expects to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us